TIAA CREF Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $275K | Sell |
63,869
-1,401
| -2% | -$6.03K | ﹤0.01% | 2805 |
|
|
2018
Q4 | $208K | Hold |
65,270
| – | – | ﹤0.01% | 2867 |
|
|
2018
Q3 | $343K | Sell |
65,270
-3,193
| -5% | -$16.8K | ﹤0.01% | 2850 |
|
|
2018
Q2 | $366K | Buy |
+68,463
| New | +$366K | ﹤0.01% | 2898 |
|
|
2016
Q2 | – | Sell |
-114,532
| Closed | -$346K | – | 3169 |
|
|
2016
Q1 | $346K | Hold |
114,532
| – | – | ﹤0.01% | 2886 |
|
|
2015
Q4 | $397K | Hold |
114,532
| – | – | ﹤0.01% | 2955 |
|
|
2015
Q3 | $433K | Hold |
114,532
| – | – | ﹤0.01% | 2925 |
|
|
2015
Q2 | $653K | Buy |
+114,532
| New | +$653K | ﹤0.01% | 2885 |
|
|
2014
Q2 | – | Sell |
-117,392
| Closed | -$556K | – | 3140 |
|
|
2014
Q1 | $556K | Hold |
117,392
| – | – | ﹤0.01% | 2910 |
|
|
2013
Q4 | $552K | Sell |
117,392
-37,448
| -24% | -$176K | ﹤0.01% | 2930 |
|
|
2013
Q3 | $617K | Sell |
154,840
-1,799
| -1% | -$7.17K | ﹤0.01% | 2878 |
|
|
2013
Q2 | $562K | Buy |
+156,639
| New | +$562K | ﹤0.01% | 2899 |
|